Covered recipient · General Payments record
RICHARD G SHERRY
Allopathic & Osteopathic Physicians Radiology Diagnostic Radiology
General Payments · PY2018–2020
$1,461.48
- Reported across 95 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2020 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $199.53 | 10 |
By paying entity
PY2020 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Genentech USA, Inc. | $59.07 | 3 |
| Amgen Inc. | $28.00 | 1 |
| Strongbridge US INC. | $27.04 | 1 |
| GENZYME CORPORATION | $22.48 | 1 |
| Biogen, Inc. | $17.57 | 1 |
| MITSUBISHI TANABE PHARMA AMERICA, INC. | $16.05 | 1 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $14.82 | 1 |
| CSL Behring | $14.50 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2020 (10)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Amgen Inc. | $28.00 | 02/25/2020 | Food and Beverage | Undisputed | 01/23/2026 | 741278825 | CMS |
| Biogen, Inc. | $17.57 | 01/12/2020 | Food and Beverage | Undisputed | 01/23/2026 | 737279283 | CMS |
| CSL Behring | $14.50 | 02/19/2020 | Food and Beverage | Undisputed | 01/23/2026 | 728981711 | CMS |
| Genentech USA, Inc. | $19.51 | 01/06/2020 | Food and Beverage | Undisputed | 01/23/2026 | 743089781 | CMS |
| Genentech USA, Inc. | $19.78 | 02/05/2020 | Food and Beverage | Undisputed | 01/23/2026 | 743089791 | CMS |
| Genentech USA, Inc. | $19.78 | 03/09/2020 | Food and Beverage | Undisputed | 01/23/2026 | 743089799 | CMS |
| GENZYME CORPORATION | $22.48 | 01/15/2020 | Food and Beverage | Undisputed | 01/23/2026 | 744158189 | CMS |
| MITSUBISHI TANABE PHARMA AMERICA, INC. | $16.05 | 02/24/2020 | Food and Beverage | Undisputed | 01/23/2026 | 750483377 | CMS |
| Novartis Pharmaceuticals Corporation | $14.82 | 01/14/2020 | Food and Beverage | Undisputed | 01/23/2026 | 726131349 | CMS |
| Strongbridge US INC. | $27.04 | 01/28/2020 | Food and Beverage | Undisputed | 01/23/2026 | 735174185 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020
- Generated from
- OP_DTL_GNRL_PGYR2020_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.